Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Foradil, Formoterol

Foradil, Formoterol News Editors

News Widget

Display the Foradil, Formoterol news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Foradil, Formoterol News

News on Foradil, Formoterol (generic) continually updated from thousands of sources around the net.

Yesterday | JD Supra

Patent Watch: Dey, L.P. v. Sunovion Pharms., Inc.

"[A]n agreement of confidentiality, or circumstances creating a similar expectation of secrecy, may negate a 'public use' where there is not commercial exploitation" [even] when an unaffiliated third party is responsible for the allegedly public use.

Comment?

Related Topix: US News, Federal Circuit Court of Appeals, Medicine, Chronic Obstructive Pulmonary Disease, Health, Copd, Inventions, Science / Technology

Mon May 13, 2013

GlobeNewswire

Pearl Therapeutics Initiates PT003 Phase 3 Program for the Treatment...

Pearl Therapeutics Inc. today announced the initiation of PINNACLE, a global Phase 3 program of PT003 , the Company's fixed-dose combination of glycopyrrolate, a long-acting muscarinic antagonist and formoterol fumarate, a long-acting beta-2 agonist , delivered via a pressurized hydrofluoroalkane using the Company's novel co-suspension formulation ... (more)

Comment?

Related Topix: Pearl Therapeutics, Medicine, Isoetharine (generic), Bronkosol, Copd

Freshnews

Assessing Your Asthma is Key to Taking Control

Approximately 25 million Americans suffer from asthma, which accounts for more than 3300 deaths each year.

Comment?

Related Topix: Medicine, Asthma, Health, AstraZeneca, Biotech, AstraZeneca Group, Healthcare Industry

Sat May 04, 2013

MediLexicon

Second Phase III Study For Aclidinium And Formoterol Combination In COPD Produces Positive Results

Aclidinium/formoterol demonstrates consistent, statistically significant lung function improvement in the second pivotal efficacy trial.

Comment?

Related Topix: Medicine, Copd, Health, Manufacturing, Automakers, TDI, Food and Drug Administration, Biotech, Forest Labs, Healthcare Industry, Chronic Obstructive Pulmonary Disease

Thu May 02, 2013

P&T Community

Positive Phase III Results With Aclidinium/Formoterol in COPD

Positive results have been reported from the AUGMENT/COPD trial, the second 6-month pivotal phase III study of investigational fixed-dose combinations of aclidinium bromide and formoterol fumarate , delivered in the Pressair inhaler.

Comment?

Related Topix: Copd, Medicine, Health

Wed May 01, 2013

Customer Interaction Solutions

Forest Laboratories and Almirall Announce Positive Results for the...

Forest Laboratories, Inc. and Almirall, S.A. today announced positive topline results from AUGMENT COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide and formoterol fumarate , delivered in the Pressair inhaler.

Comment?

Related Topix: Biotech, Medicine, Forest Labs, Healthcare Industry, Forest Laboratories, Copd, Health